Evidence map›Paper›PMID 36454055›Full record

ArticleUnited European gastroenterology journal2023

Post-pancreatitis diabetes mellitus is common in chronic pancreatitis and is associated with adverse outcomes.

Ana Dugic, Hannes Hagström, Ingrid Dahlman, Wiktor Rutkowski, Diana Daou, Paula Kulinski, J-Matthias Löhr, Miroslav Vujasinovic

Open access · bronzeAbstract read
In one paragraph

Article in United European gastroenterology journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 33 citations in OpenAlex.

  1. Computed Tomography and Plasma Proteomics for Early Discrimination of Post-Pancreatitis Diabetes Mellitus.Medical science monitor : international medical journal of experimental and clinical research · 2026
    Article
  2. Article
  3. Article
  4. Early mechanisms of diabetes development in pediatric pancreatitis: A pilot study.Journal of pediatric gastroenterology and nutrition · 2026
    Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Risk Factors and Mechanisms for Diabetes in Pancreatitis.Gastroenterology clinics of North America · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Ana DugicDepartment of Medicine, Huddinge, Karolinska Institute, Stockholm, Sweden.ORCID 0000-0002-1893-0754
Hannes HagströmDepartment of Medicine, Huddinge, Karolinska Institute, Stockholm, Sweden.ORCID 0000-0002-8474-1759
Ingrid DahlmanDepartment of Medicine, Huddinge, Karolinska Institute, Stockholm, Sweden.ORCID 0000-0003-3819-5977
Wiktor RutkowskiDepartment of Medicine, Huddinge, Karolinska Institute, Stockholm, Sweden.ORCID 0000-0002-0471-1673
Diana DaouDepartment of Medicine, Huddinge, Karolinska Institute, Stockholm, Sweden.ORCID 0000-0002-1218-3663
Paula KulinskiDepartment of Medicine, Huddinge, Karolinska Institute, Stockholm, Sweden.ORCID 0000-0002-3714-4409
J-Matthias LöhrDepartment of Upper Abdominal Diseases, Karolinska University Hospital, Stockholm, Sweden.ORCID 0000-0002-7647-198X
Miroslav VujasinovicDepartment of Medicine, Huddinge, Karolinska Institute, Stockholm, Sweden.ORCID 0000-0002-6496-295X
Karolinska Institutet · SEKarolinska University Hospital · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPost-pancreatitis diabetes mellitus (PPDM) is a common consequence of chronic pancreatitis (CP). We aimed to determine the incidence and predictors of PPDM after CP onset, as well as complications and antidiabetic therapy requirements, in a high-volume tertiary center.

methodsWe did a cohort study with retrospectively collected data from patients with definite CP seen at the Karolinska University Hospital between January 1999 and December 2020. Cause-specific Cox regression analysis was used to assess PPDM predictors. To estimate risk of complications and need for therapy the Fine-Gray subdistribution hazard model was employed, accounting for death as a competing risk.

resultsWe identified 481 patients with CP. The cumulative incidence of PPDM was 5.1%, 13.2%, 27.5% and 38.9% at 5, 10, 15 and 20 years, respectively. Compared to CP patients without diabetes, patients with PPDM were predominantly male (55% vs. 75%), had more frequently alcoholic etiology (44% vs. 62%) and previous acute pancreatitis. The only independent predictor of PPDM was presence of pancreatic calcifications (aHR = 2.45, 95% CI 1.30-4.63). Patients with PPDM had higher rates of microangiopathy (aSHR = 1.59, 95% CI 1.02-2.52) and infection (aSHR = 4.53, 95% CI 2.60-9.09) compared to CP patients who had type 2 diabetes (T2DM). The rate of insulin use was three-fold higher, whereas metformin use rate was two-fold higher in the same comparison.

conclusionsPatients with PPDM have a higher frequency of clinically significant complications and were more commonly prescribed insulin and metformin, suggesting a more aggressive phenotype than that of T2DM. Greater PPDM awareness is needed to optimize disease management.

Indexed as

Diabetes Mellitus, Type 2InsulinsMetforminPancreatitis, ChronicAcute DiseaseCohort StudiesFemaleHumansMaleRetrospective StudiesInsulinsMetforminchronic pancreatitiscomplicationsdiabetes mellitusinsulinpost-pancreatitis

Identifiers

PMID36454055
PMCPMC9892477
OpenAlexW4310494119

What Socratic holds

Texttitle and abstract
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.